ITF Therapeutics: New data and analyses presented on DUVYZAT® (givinostat) at 2026 MDA Clinical and Scientific Conference

March 11, 2026

On March 11, 2026, ITF Therapeutics shared a Community Letter outlining new data and analyses presented on DUVYZAT® (givinostat) at 2026 MDA Clinical and Scientific Conference.

To view their Community Letter, please click here.